STATCenter·
STAT+: AbbVie wins FDA nod for Parkinson’s pill
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
Read at STAT →
Health · 1 sources covering this
STAT+: AbbVie wins FDA nod for Parkinson’s pill
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/28a6aba9f7a423b3db5abb87298005acced12b5c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: AbbVie wins FDA nod for Parkinson’s pill"></iframe>
